{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:07:19Z","timestamp":1790172439100,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Long non\u2010coding RNA taurine\u2010upregulated gene 1 (lncRNA TUG1) is reported to be involved in the progression and development of several malignancies; however, its role in Philadelphia chromosome\u2010negative acute lymphoblastic leukemia (Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL) is unknown. The present study aimed to explore the correlation of lncRNA TUG1 with disease risk, disease condition, and prognosis of adult Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Total 101 adult Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL patients and 40 bone marrow (BM) donors were included, followed by detection of BM monocyte cell lncRNA TUG1 expression by reverse transcription\u2010quantitative polymerase chain reaction. According to the quantiles of lncRNA TUG1 expression in Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL patients, these patients were divided into four tiers: tier 1 (ranked in 0%~25%), tier 2 (ranked in 25%~50%), tier 3 (ranked in 50%~75%), and tier 4 (ranked in 75%~100%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LncRNA TUG1 was upregulated in Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL patients compared with healthy donors. Further analysis indicated that in Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL patients, higher lncRNA TUG1 tier was correlated with the presence of central nervous system leukemia, increased white blood cell level, and bone marrow blasts. Furthermore, higher lncRNA TUG1 tier was negatively associated with complete remission (CR) within 4\u00a0weeks, total CR, and allogeneic hematopoietic stem cell transplant achievement. In addition, higher lncRNA TUG1 tier was associated with decreased disease\u2010free survival and overall survival, which was further verified to be an independent factor by Cox's regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      lncRNA TUG1 presents potential to be a novel biomarker for disease risk assessment and survival surveillance in Ph\n                      <jats:sup>\u2212<\/jats:sup>\n                      ALL management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jcla.23583","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T05:49:47Z","timestamp":1626068987000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Correlation analysis of long non\u2010coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph\n                    <sup>\u2212<\/sup>\n                    Acute lymphoblastic leukemia"],"prefix":"10.1002","volume":"35","author":[{"given":"Pengyun","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-9335","authenticated-orcid":false,"given":"Chongge","family":"You","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology Lanzhou University, Second Hospital  Lanzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0024"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2012.0089"},{"issue":"1","key":"e_1_2_5_4_1","first-page":"23","article-title":"Topics in pediatric leukemia\u2013acute lymphoblastic leukemia","volume":"7","author":"Esparza SD","year":"2005","journal-title":"Med Gen Med"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1623"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116582"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S234935"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S167900"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0771-x"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000479990"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmz069"},{"issue":"47","key":"e_1_2_5_12_1","first-page":"42","article-title":"Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myeloma","volume":"79","author":"Yin Q","year":"2019","journal-title":"Exp Hematol"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.02.010"},{"issue":"9","key":"e_1_2_5_14_1","first-page":"789","article-title":"[A Chinese expert panel consensus on diagnosis and treatment of adult acute lymphoblastic leukemia]","volume":"33","author":"Chinese Society of Hematology CMA","year":"2012","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-019-1430-4"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1556214"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.06.085"},{"issue":"19","key":"e_1_2_5_18_1","first-page":"8211","article-title":"LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2","volume":"23","author":"Duan W","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182489"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1024\/0040-5930\/a001127"},{"issue":"11","key":"e_1_2_5_21_1","first-page":"4584","article-title":"LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt\/beta\u2010catenin signaling pathway","volume":"23","author":"Liu SC","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"e_1_2_5_22_1","first-page":"325","article-title":"Expression of osteopontin in central nervous system leukemia and its clinical significance","volume":"21","author":"Fang XM","year":"2013","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.152926"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.23583","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcla.23583","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.23583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:39:06Z","timestamp":1790170746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.23583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1002\/jcla.23583"],"URL":"https:\/\/doi.org\/10.1002\/jcla.23583","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"2020-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e23583"}}